Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

BLPH Bellerophon Therapeutics

1.1300.0000.00%
Close 10/05 16:00 ET
High
1.139
Open
1.057
Turnover
8.00K
Low
1.057
Pre Close
1.130
Volume
7.12K
Market Cap
10.79M
P/E(TTM)
Loss
52wk High
4.490
Shares
9.55M
P/E(Static)
Loss
52wk Low
0.670
Float Cap
7.90M
Bid/Ask %
92.31%
Historical High
193.800
Shs Float
6.99M
Volume Ratio
0.34
Historical Low
0.670
Dividend TTM
--
Div Yield TTM
--
P/B
0.88
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.10%
Amplitude
7.20%
Avg Price
1.123
Lot Size
1
Float Cap
7.90M
Bid/Ask %
92.31%
Historical High
193.800
Shs Float
6.99M
Volume Ratio
0.34
Historical Low
0.670
Dividend TTM
--
P/B
0.88
Dividend LFY
--
Turnover Ratio
0.10%
Amplitude
7.20%
Avg Price
1.123
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.
CEO: Mr. Peter Fernandes
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...